X

Advanced Search

Select a search constraint:



ArrowEvolution™ with Chlorag<sup>+</sup>ard™ technology

We've rethought the PICC from the inside out.

aiming for zero central-line associated infections

Suspected origins of central line–associated bloodstream infection (CLABSI)

Microorganisms that compromise peripherally inserted central catheters (PICC)

Left unchecked, microorganisms attach to living tissue or nonliving material, including indwelling medical devices. These organisms can originate from many places, including microflora on the patient's skin. Despite every precaution, these organisms may be acquired in the hospital environment and subsequently transferred to catheter hubs and lines. Colonization of bacteria and fungi can then lead to an emergent infection.1

Frequency of antimicrobial-resistant pathogens in 463 hospitals2

According to the National Healthcare Safety Network, from 2006 to 2007 the 10 most common pathogens accounting for 89.5% of CLABSIs were

  1. Coagulase-negative staphylococci (34.1%)
  2. Enterococcus species (16.0%)
  3. Candida species (11.8%)
  4. Staphylococcus aureus (9.9%)
  5. Klebsiella pneumoniae (4.9%)
  6. Enterobacter species (3.9%)
  7. Pseudomonas aeruginosa (3.1%)
  8. Escherichia coli (2.7%)
  9. Acinetobacter baumannii (2.2%)
  10. Klebsiella oxytoca (0.9%)

Fight microbial colonization at the source

Did you know?

  • 85% of infection preventionists3 and 81% of vascular access specialists4 are very or somewhat concerned about infection rates with PICC placements
  • 73% of infection preventionists3 and 73% of vascular access specialists4 rated the importance of antimicrobial protection on a PICC as extremely or very important

ArrowEVOLUTION with Chlorag+ard technology provides both extraluminal and intraluminal antimicrobial protection, from tip to hub. The chlorhexidine-treated catheter provides a proven 99.99% reduction in colonization* of gram-positive and gram-negative bacteria and fungi, including organisms such as MRSA, VRE, Staphylococcus epidermidis, Candida albicans and Acinetobacter baumannii3

Instructions for use (PDFPDF 970k)

  • Request more information on ArrowEVOLUTION PICC
  • FirstDoNoHarm.com

*Based on in vitro data.

References: 1. Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis. 2001;7:277-281. 2. Hidron AI, Edwards JR, Patel J, et al; for the National Healthcare Safety Network Team and participating National Healthcare Safety Network facilities. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol. 2008;29:996-1011. 3. Data on file, 2010 APIC Survey, Teleflex Incorporated. 4. Data on file, 2010 INS Survey, Teleflex Incorporated.

Teleflex, ArrowEVOLUTION, Chlorag+ard and ZERO ZONE are trademarks or registered trademarks of Teleflex Incorporated or its affiliates.